White House, Senate leaders announce deal on $2T coronavirus stimulus package

The White House and leaders in the Senate early Wednesday announced that they've reached an agreement on a $2 trillion legislative package intended to stimulate the economy and help Americans, health care providers, and businesses grappling with the United States' coronavirus epidemic.

Read More

COVID-19 roundup: University Hospitals develops app to let providers monitor patients remotely

FDA has approved Cepheid's point-of-care diagnostic test for COVID-19, Gilead secures orphan status for remdesivir, and more.

Loss of smell and taste: A new COVID-19 warning sign?

A pair of ear, nose, and throat doctors in the United Kingdom on Friday published a statement warning doctors that anosmia, or loss of sense of smell, and ageusia, diminished sense of taste, could be symptoms of COVID-19, the disease caused by the new coronavirus.

Desperate patients are turning to endocrinologists, dermatologists—and even dentists—for COVID-19 help

Health care providers across the country are being inundated with patient questions about the new coronavirus—but not every provider is trained to handle respiratory infections, and some are struggling to answer patients' questions and calm rising anxieties, Emma Goldberg reports for the New York Times.

Around the nation: Doctors warn against taking chloroquine products for COVID-19

The Arizona man and his wife ingested an aquarium product that contained large amounts of chloroquine after reading online that the compound may help combat the new coronavirus, in today's bite-sized hospital and health industry news from Arizona, Pennsylvania, and Rhode Island.

What are the 'Emergency Use Authorizations' the FDA keeps issuing, and how do they reduce barriers to COVID-19 testing?

Providers and labs testing the first wave of COVID-19 patients were hamstrung by FDA policies that limited availability of diagnostic tests. But in the past month, FDA has leveraged Emergency Use Authorizations to greatly expand testing options. Advisory Board's Abby Burns explains how these authorizations work—and how they're being used to increase access to diagnostic tests.

Why COVID-19 could make social determinants of health even worse

The vast majority of health care leaders' attention is rightly focused on the new coronavirus and preparing for a surge in patient cases. However, provider organizations risk long-term damage to community health if leaders don't also attempt to mitigate the epidemic's impact on the social determinants of health, Advisory Board's Darby Sullivan and Emily Connelly write.